Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis

Journal of Clinical Oncology

Volumn 31, Issue 36, 2013, Pages 4488-4495

  Mukesh, Mukesh B ^a   Barnett, Gillian C ^a   Wilkinson, Jennifer S ^a   Moody, Anne M ^a   Wilson, Charles ^a   Dorling, Leila ^a   Hak, Charleen Chan Wah ^b   Qian, Wendi ^a   Twyman, Nicola ^a   Burnet, Neil G ^b   Wishart, Gordon C ^c   Coles, Charlotte E ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL ASSESSMENT; CONTROLLED STUDY; EDEMA; FEMALE; FOLLOW UP; HUMAN; HYPOTHESIS; INTENSITY MODULATED RADIATION THERAPY; INTRADUCTAL CARCINOMA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PHOTOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SKIN INDURATION; SKIN PIGMENTATION; STANDARD; TELANGIECTASIA; UNIVARIATE ANALYSIS; VERY ELDERLY; ADJUVANT THERAPY; BREAST TUMOR; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED CLINICAL TRIAL; ESTHETICS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PATIENT SATISFACTION; PIGMENT DISORDER; RISK; SEGMENTAL MASTECTOMY; STATISTICAL MODEL; TREATMENT OUTCOME; BREAST NEOPLASMS; PIGMENTATION DISORDERS; TELANGIECTASIS;

ADULT; AGED; BEAUTY; BREAST NEOPLASMS; EDEMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; PATIENT SATISFACTION; PHOTOGRAPHY; PIGMENTATION DISORDERS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; TELANGIECTASIS; TREATMENT OUTCOME;

EID: 84894452493     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.49.7842     Document Type: Article

References (22)

1. Darby S, McGale P, Correa C, et al: Effect of radiotherapy after breast-conserving surgery on 10- year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378:1707- 1716, 2011
2. Al-Ghazal SK, Fallowfield L, Blamey RW: Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity? Eur J Surg Oncol 25:571-573, 1999
3. Kestin LL, Sharpe MB, Frazier RC, et al: Intensity modulation to improve dose uniformity with tangential breast radiotherapy: Initial clinical experience. Int J Radiat Oncol Biol Phys 48:1559- 1568, 2000
4. Vicini FA, Sharpe M, Kestin L, et al: Optimizing breast cancer treatment efficacy with intensitymodulated radiotherapy. Int J Radiat Oncol Biol Phys 54:1336-1344, 2002 (Pubitemid 35380033)
5. Donovan E, Bleakley N, Denholm E, et al: Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 82:254-264, 2007 (Pubitemid 46341474)
6. Barnett GC, Wilkinson JS, Moody AM, et al: Randomized controlled trial of forward-planned intensity modulated radiotherapy for early breast cancer: Interim results at 2 years. Int J Radiat Oncol Biol Phys 82:715-723, 2012
7. Pignol JP, Olivotto I, Rakovitch E, et al: A multicenter randomized trial of breast intensitymodulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 26:2085-2092, 2008
8. van der Laan HP, Hurkmans CW, Kuten A, et al: Current technological clinical practice in breast radiotherapy: Results of a survey in EORTCRadiation Oncology Group affiliated institutions. Radiother Oncol 94:280-285, 2010
9. Smith BD, Pan IW, Shih YC, et al: Adoption of intensity-modulated radiation therapy for breast cancer in the United States. J Natl Cancer Inst 103:798- 809, 2011
10. Kachnic LA, Powell SN: IMRT for breast cancer: Balancing outcomes, patient selection, and resource utilization. J Natl Cancer Inst 103:777-779, 2011
11. McCormick B, Hunt M: Intensity-modulated radiation therapy for breast: Is it for everyone? Semin Radiat Oncol 21:51-54, 2011
12. Barnett GC, Wilkinson J, Moody AM, et al: A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: Baseline characteristics and dosimetry results. Radiother Oncol 92:34-41, 2009
13. Haviland JS, Ashton A, Broad B, et al: Evaluation of a method for grading late photographic change in breast appearance after radiotherapy for early breast cancer. Clin Oncol (R Coll Radiol) 20: 497-501, 2008
14. Agrawal RK, Alhasso A, Barrett-Lee PJ, et al: First results of the randomised UK FAST trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015). Radiother Oncol 100:93-100, 2011
15. Cardoso MJ, Cardoso J, Amaral N, et al: Turning subjective into objective: The BCCT.core software for evaluation of cosmetic results in breast cancer conservative treatment. Breast 16:456-461, 2007 (Pubitemid 47500034)
16. Bentzen SM, Agrawal RK, Aird EG, et al: The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet 371:1098-1107, 2008
17. Bentzen SM, Agrawal RK, Aird EG, et al: The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial. Lancet Oncol 9:331-341, 2008
18. Donovan EM, Bleackley NJ, Evans PM, et al: Dose-position and dose-volume histogram analysis of standard wedged and intensity modulated treatments in breast radiotherapy. Br J Radiol 75:967- 973, 2002 (Pubitemid 36149761)
19. Vrieling C, Collette L, Fourquet A, et al: The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial: EORTC Radiotherapy and Breast Cancer Cooperative Groups - European Organisation for Research and Treatment of Cancer. Int J Radiat Oncol Biol Phys 45:677-685, 1999
20. Moody AM, Mayles WP, Bliss JM, et al: The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol 33:106-112, 1994
21. Goldsmith C, Haviland J, Tsang Y, et al: Large breast size as a risk factor for late adverse effects of breast radiotherapy: Is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation? Radiother Oncol 100:236-240, 2011
22. De Neve W, De Gersem W, Madani I: Rational use of intensity-modulated radiation therapy: The importance of clinical outcome. Semin Radiat Oncol 22:40-49, 2012